title: Negative feedback regulation of wild-type p53 biosynthesis.
abstract: When growth-arrested mouse fibroblasts re-entered the cell-cycle, the rise in tumour suppressor p53 mRNA level markedly preceded the rise in expression of the p53 protein. Furthermore, gamma-irradiation of such cells led to a rapid increase in p53 protein biosynthesis even in the presence of the transcription inhibitor actinomycin D. Both findings strongly suggest that p53 biosynthesis in these cells is regulated at the translational level. We present evidence for an autoregulatory control of p53 expression by a negative feed-back loop: p53 mRNA has a predicted tendency to form a stable stem-loop structure that involves the 5'-untranslated region (5'-UTR) plus some 280 nucleotides of the coding sequence. p53 binds tightly to the 5'-UTR region and inhibits the translation of its own mRNA, most likely mediated by the p53-intrinsic RNA re-annealing activity. The inhibition of p53 biosynthesis requires wild-type p53, as it is not observed with MethA mutant p53, p53-catalysed translational inhibition is selective; it might be restricted to p53 mRNA and a few other mRNAs that are able to form extensive stem-loop structures. Release from negative feed-back regulation of p53 biosynthesis, e.g. after damage-induced nuclear transport of p53, might provide a means for rapidly increasing p53 protein levels when p53 is required to act as a cell-cycle checkpoint determinant after DNA damage.
authors.affiliation: Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Universität Hamburg, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Mosner
authors.forename: T
authors.initials: T
authors.lastname: Mummenbrauer
authors.forename: C
authors.initials: C
authors.lastname: Bauer
authors.forename: G
authors.initials: G
authors.lastname: Sczakiel
authors.forename: F
authors.initials: F
authors.lastname: Grosse
authors.forename: W
authors.initials: W
authors.lastname: Deppert
mesh_terms: D016475:3T3 Cells / Q000166:cytology; D000818:Animals; D002453:Cell Cycle / Q000502:physiology*; D002478:Cells, Cultured; D004249:DNA Damage; D003609:Dactinomycin / Q000494:pharmacology; D005246:Feedback; D005720:Gamma Rays / Q000009:adverse effects; D005786:Gene Expression Regulation; D051379:Mice; D009690:Nucleic Acid Conformation; D011485:Protein Binding; D014176:Protein Biosynthesis; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D016601:RNA-Binding Proteins / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D014158:Transcription, Genetic; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism
chemical_list: D011500:Protein Synthesis Inhibitors; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; D016159:Tumor Suppressor Protein p53; D003609:Dactinomycin